Pure Global: Singapore AI MedTech - Navigating HSA's New High-Stakes Regulatory Maze. episode artwork

EPISODE · Mar 16, 2026 · 1 MIN

Pure Global: Singapore AI MedTech - Navigating HSA's New High-Stakes Regulatory Maze.

from ASEAN MedTech Insights

This week on ASEAN MedTech Insights, we dissect the groundbreaking new guidelines from Singapore's Health Sciences Authority (HSA) for AI-powered medical devices. As Singapore aims to become a global leader in health innovation, what do these stringent new rules mean for manufacturers and their path to market? We explore the critical shift from static validation to continuous lifecycle management for adaptive AI. This isn't just another regulatory update; it's a fundamental change in how AI safety, efficacy, and evolution are managed in one of Asia's most critical MedTech markets. Consider this scenario: Your company is ready to launch a revolutionary AI diagnostic tool in Singapore. Suddenly, you discover that your entire clinical validation and post-market strategy is obsolete under the HSA's new framework, which now demands a pre-approved plan for real-world performance monitoring. This could delay your launch by months and add significant unexpected costs to your budget. Key Questions This Episode Answers: * What specific changes must be made to a technical dossier to comply with the HSA's new AI guidelines? * How can you design a post-market surveillance plan for an AI that constantly learns and adapts? * What are the new cybersecurity and data governance requirements for AI medical devices in Singapore? * How does this new framework impact the cost and timeline for market entry? * What kind of real-world clinical data is the HSA now expecting for AI validation? * How can startups future-proof their AI device submissions against evolving regulations? * What are the hidden risks of failing to comply with these lifecycle management requirements? At Pure Global, we specialize in demystifying complex regulatory pathways. From AI-driven technical dossier preparation to developing robust post-market surveillance plans, our blend of local expertise and advanced data tools provides end-to-end solutions to get your MedTech innovation to market faster. Contact us for a strategic consultation at [email protected] or visit https://pureglobal.com/.

Episode metadata supplied by the publisher feed · Published Mar 16, 2026

Embed this episode

NOW PLAYING

Pure Global: Singapore AI MedTech - Navigating HSA's New High-Stakes Regulatory Maze.

0:00 1:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ASEAN MedTech Insights?

This episode is 1 minute long.

When was this ASEAN MedTech Insights episode published?

This episode was published on March 16, 2026.

Can I download this ASEAN MedTech Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!